Categories :

Can adjuvant chemotherapy be used in treatment of lung cancer?

Can adjuvant chemotherapy be used in treatment of lung cancer?

Adjuvant chemotherapy (AC) plays now a significant role in the treatment of resected non-small cell lung cancer (NSCLC) patients and has become standard in clinical practice.

What chemo drugs are used for lung cancer?

The chemo drugs most often used for NSCLC include:

  • Cisplatin.
  • Carboplatin.
  • Paclitaxel (Taxol)
  • Albumin-bound paclitaxel (nab-paclitaxel, Abraxane)
  • Docetaxel (Taxotere)
  • Gemcitabine (Gemzar)
  • Vinorelbine (Navelbine)
  • Etoposide (VP-16)

Who should receive adjuvant chemotherapy?

Adjuvant chemotherapy should be offered to patients whose breast cancer is of high enough risk that the patient and the physician accept the associated toxic effects. Indications generally include tumors greater than 1 cm, node-positive disease, or ER-negative cancers.

Is adjuvant considered first line chemo?

“Adjuvant therapy,” such as chemotherapy given before surgery to reduce the size of a tumor, or after surgery to reduce the risk of recurrence, is considered a component of first-line therapy in this setting. First-Line vs. Second-Line Treatment

What is adjuvant radiation therapy?

Adjuvant radiation therapy consists of focused gamma rays, X-rays and charged particles directed to the tumor site. Radiation therapy can be delivered externally, that is, from a machine outside the body, or internally from radioactive particles implanted near the tumor.

How is chemotherapy used to treat lung cancer?

Chemotherapy is a lung cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Doctors also use chemotherapy to help reduce pain and other problems caused by lung cancer. This treatment may be given alone, with radiation, or with surgery and radiation.

What does chemotherapy, adjuvant mean?

adjuvant chemotherapy. the use of anticancer drugs after or in combination with another form of cancer treatment, as after apparently complete surgical removal of cancer cells. The method is used when there is a significant risk that micrometastasis may still be present.